Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality in Hong Kong. Health coaching intervention are generally effective for managing chronic disease and prevention of complication. However, there is fewer attention on the effects of health coaching in primary disease prevention. This study aims to evaluate the effects of health coaching programme on increasing health promoting behaviours in middle-aged adults with cardiometabolic risk.
Cardiometabolic disease, including metabolic syndrome, prediabetes, type 2 diabetes mellitus, coronary heart disease, myocardial infarction and stroke, has been an increasing trend globally, and increased more than double over 5 years in China \[1\]. Cardiometabolic disease remains the major cause of morbidity and mortality in Hong Kong \[2\]. Type 2 diabetes mellitus is associated with increased risk for morbidity and mortality \[3\]. Ischaemic heart disease and stroke were the major cause of disability-adjusted life years (DALYs) worldwide, resulting in dependence, disability and cognitive impairment \[4\]. Moreover, midlife stroke risk is associated with cognitive decline within 10 years \[5\]. A local population health survey has reported that 41.1% of persons between the ages of 45 and 64 are at medium-to-high risk of developing cardiovascular diseases over the next 10 years \[6\]. Most of the cardiometabolic diseases are attributable to health behaviours. An international study identified risk factors for coronary heart disease and validated the non-laboratory INTERHEART Risk Score (IHRS), which is mainly calculated based on behavioural risk factors, including smoking, stress and physical activity \[7\]. Also, another study among 32 countries in Asia, Africa, Australia, Europe, the Middle East and USA reported that over 90% of the population attributable risks of stroke could be explained by behavioural risk factors measured by IHRS \[8\]. Proactive measures to moderate these modifiable risk factors are crucial to halt the increasing trend of cardiometabolic disease. Health coaching interventions are generally effective for managing chronic diseases, including cancer, heart disease, diabetes and hypertension \[9\]. A systematic review reported health coaching significantly increased physical activity, improved physical and mental health status in patients with chronic disease \[10\]. Health coaching interventions assist patients to participate actively in their health care, and health coaches collaborate with patients by giving support and promoting self-efficacy in disease management \[11\]. Despite the widespread use of evidence based health coaching in chronic disease management and prevention of complication, there is fewer attention on the effects of health coaching in primary disease prevention. Therefore, a large-scale, robust clinical trial examining the effects of health coaching in reducing the cardiometabolic risk in middle-aged adults is warranted. The purpose of this study is to address the research gap by evaluating the effects of health coaching programme on increasing health promoting behaviours in middle-aged adults with cardiometabolic risk.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
202
The health coaching program includes four monthly health coaching sessions for three months.
The Chinese University of Hong Kong
Hong Kong, Hong Kong
RECRUITINGChange in health promoting behaviours
The Chinese version of Health Promoting Lifestyle Profile II (HPLP II) , including health responsibility (9 items), nutrition (9 items), physical activity (8 items) and stress management (8 items), measure the practice of health-promoting behaviours
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in cardiometabolic risk
Non-laboratory INTERHEART Risk Score (IHRS) assess the risk of cardiometabolic disease
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in stroke risk
Automatic retinal image analysis (ARIA)-stroke will be used to quantify stroke risk
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in self-efficacy of adopting health promoting behaviours
Adapted version of the Diabetes Mellitus Type II Self Efficacy Scale will be used to rate the participants level of confidence in various behaviours
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in psychological distress
The Chinese version of the shorter version of Depression Anxiety Stress Scales (DASS) developed by Lovibond and Lovibond in 1995 will be used
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in sleep quality
The Chinese version of the Pittsburg Sleep Quality Index developed by Buysse and team in 1988 will be used
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in physical activities
International Physical Activity Questionnaire - Chinese (IPAQ-C), a short version, 9-item scale, will be used to assess the level of physical activities
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in systolic blood pressure
Blood pressure measurement using an electronic sphygmomanometer
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in diastolic blood pressure
Blood pressure measurement using an electronic sphygmomanometer
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in Body Mass Index
Body Mass Index will be calculated by the measured height and weight
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in waist-hip-ratio
Waist-hip-ration will be calculated by the measured waist and hip circumference
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in blood glucose
Point of care testing of blood for glucose
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in blood total cholesterol
Point of care testing of blood for total cholesterol
Time frame: Change from baseline at 3 months and 6 months post allocation
Change in blood urate
Point of care testing of blood for urate
Time frame: Change from baseline at 3 months and 6 months post allocation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.